Is There a Rationale for Haemoadsorption with Combined Use of CytoSorb<sup>®</sup> and Oxiris<sup>®</sup> in Patients with Underlying Viral Infection and Secondary Bacterial Sepsis? [PDF]
Wrzosek A +6 more
europepmc +1 more source
Lactate Clearance of the Adsorber Cytosorb® in Critically Ill Patients: A Post-Hoc Analysis of the Cyto-SOLVE Trial. [PDF]
Wustrow V +7 more
europepmc +1 more source
A Contemporary Review of the Use of Extracorporeal CytoSorb® Hemoadsorption Therapy in Patients with Infective Endocarditis. [PDF]
Gong A, Li Y, Yang M, Wang S, Su B.
europepmc +1 more source
Extracorporeal Elimination of Pro- and Anti-inflammatory Modulators by the Cytokine Adsorber CytoSorb® in Patients with Hyperinflammation: A Prospective Study. [PDF]
Graf H +10 more
europepmc +1 more source
Correction: Impact of hemoadsorption with CytoSorb<sup>®</sup> on meropenem and piperacillin exposure in critically ill patients in a post-CKRT setup: a single-center, retrospective data analysis. [PDF]
Asgarpur G +8 more
europepmc +1 more source
Potential correlation between hemodynamic improvement and an immune-modulation effect in pediatric patients with septic shock treated with renal replacement therapy and CytoSorb®: an insight from the PedCyto study. [PDF]
Bottari G +4 more
europepmc +1 more source
Related searches:

